PAA 2.27% 22.5¢ pharmaust limited

Ann: Investor Briefings & Webinar Notice, page-50

  1. 2,873 Posts.
    lightbulb Created with Sketch. 1055
    ........In discussions with Elanco for their MPL patent. .....

    Did he say this? What I got was the composition of matter IP which belong to Elanco run out worldwide by the end of next year (2025) so they don't represent a hinderance to the marketing, development and commercialisation of MPL.

    Nice to finally get full clarity on the IP expiry and the timing seems to confirm the deliberate "go-slow" by the previous regime although this was constantly denied. Full transparency by the good Dr T and his PAA team is certainly much appreciated
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $100.1M
Open High Low Value Volume
22.0¢ 22.5¢ 21.5¢ $194.1K 889.8K

Buyers (Bids)

No. Vol. Price($)
2 4996 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 114999 4
View Market Depth
Last trade - 16.10pm 16/07/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.